Share-based Payment Arrangement, Expense of Caribou Biosciences, Inc. from 31 Dec 2019 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Caribou Biosciences, Inc. quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 31 Dec 2019 to 31 Dec 2025.
  • Caribou Biosciences, Inc. Share-based Payment Arrangement, Expense for the quarter ending 31 Dec 2025 was $2,738,000, a 30% decline year-over-year.
  • Caribou Biosciences, Inc. Share-based Payment Arrangement, Expense for the twelve months ending 31 Dec 2025 was $12,680,000, a 24% decline year-over-year.
  • Caribou Biosciences, Inc. annual Share-based Payment Arrangement, Expense for 2025 was $12,680,000, a 24% decline from 2024.
  • Caribou Biosciences, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $16,706,000, a 21% increase from 2023.
  • Caribou Biosciences, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $13,750,000, a 17% increase from 2022.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

Caribou Biosciences, Inc. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $12,680,000 $2,738,000 -$1,173,000 -30% 01 Oct 2025 31 Dec 2025 10-K 05 Mar 2026 2025 FY
Q3 2025 $13,853,000 $2,931,000 -$1,138,000 -28% 01 Jul 2025 30 Sep 2025 10-Q 12 Nov 2025 2025 Q3
Q2 2025 $14,991,000 $3,129,000 -$1,609,000 -34% 01 Apr 2025 30 Jun 2025 10-Q 12 Aug 2025 2025 Q2
Q1 2025 $16,600,000 $3,882,000 -$106,000 -2.7% 01 Jan 2025 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 $16,706,000 $3,911,000 +$355,000 +10% 01 Oct 2024 31 Dec 2024 10-K 05 Mar 2026 2025 FY
Q3 2024 $16,351,000 $4,069,000 +$591,000 +17% 01 Jul 2024 30 Sep 2024 10-Q 12 Nov 2025 2025 Q3
Q2 2024 $15,760,000 $4,738,000 +$1,153,000 +32% 01 Apr 2024 30 Jun 2024 10-Q 12 Aug 2025 2025 Q2
Q1 2024 $14,607,000 $3,988,000 +$857,000 +27% 01 Jan 2024 31 Mar 2024 10-Q 08 May 2025 2025 Q1
Q4 2023 $13,750,000 $3,556,000 +$455,000 +15% 01 Oct 2023 31 Dec 2023 10-K 10 Mar 2025 2024 FY
Q3 2023 $13,295,000 $3,478,000 +$805,000 +30% 01 Jul 2023 30 Sep 2023 10-Q 06 Nov 2024 2024 Q3
Q2 2023 $12,490,000 $3,585,000 +$667,000 +23% 01 Apr 2023 30 Jun 2023 10-Q 06 Aug 2024 2024 Q2
Q1 2023 $11,823,000 $3,131,000 +$107,000 +3.5% 01 Jan 2023 31 Mar 2023 10-Q 07 May 2024 2024 Q1
Q4 2022 $11,716,000 $3,101,000 +$1,523,000 +97% 01 Oct 2022 31 Dec 2022 10-K 11 Mar 2024 2023 FY
Q3 2022 $10,193,000 $2,673,000 +$1,738,000 +186% 01 Jul 2022 30 Sep 2022 10-Q 07 Nov 2023 2023 Q3
Q2 2022 $8,455,000 $2,918,000 +$2,325,000 +392% 01 Apr 2022 30 Jun 2022 10-Q 08 Aug 2023 2023 Q2
Q1 2022 $6,130,000 $3,024,000 +$2,681,000 +782% 01 Jan 2022 31 Mar 2022 10-Q 09 May 2023 2023 Q1
Q4 2021 $3,449,000 $1,578,000 01 Oct 2021 31 Dec 2021 10-K 09 Mar 2023 2022 FY
Q3 2021 $935,000 +$687,000 +277% 01 Jul 2021 30 Sep 2021 10-Q 08 Nov 2022 2022 Q3
Q2 2021 $593,000 +$307,000 +107% 01 Apr 2021 30 Jun 2021 10-Q 09 Aug 2022 2022 Q2
Q1 2021 $343,000 01 Jan 2021 31 Mar 2021 10-Q 09 May 2022 2022 Q1
Q3 2020 $248,000 01 Jul 2020 30 Sep 2020 10-Q 09 Nov 2021 2021 Q3
Q2 2020 $286,000 01 Apr 2020 30 Jun 2020 10-Q 02 Sep 2021 2021 Q2

Caribou Biosciences, Inc. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $12,680,000 -$4,026,000 -24% 01 Jan 2025 31 Dec 2025 10-K 05 Mar 2026 2025 FY
2024 $16,706,000 +$2,956,000 +21% 01 Jan 2024 31 Dec 2024 10-K 05 Mar 2026 2025 FY
2023 $13,750,000 +$2,034,000 +17% 01 Jan 2023 31 Dec 2023 10-K 10 Mar 2025 2024 FY
2022 $11,716,000 +$8,267,000 +240% 01 Jan 2022 31 Dec 2022 10-K 11 Mar 2024 2023 FY
2021 $3,449,000 +$2,447,000 +244% 01 Jan 2021 31 Dec 2021 10-K 09 Mar 2023 2022 FY
2020 $1,002,000 -$232,000 -19% 01 Jan 2020 31 Dec 2020 10-K 21 Mar 2022 2021 FY
2019 $1,234,000 01 Jan 2019 31 Dec 2019 10-K 21 Mar 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.